Show simple item record

Investigating alterations in cancer driver genes and other potentially targetable mutations in patients with intrahepatic cholangiocarcinoma (iCCA) treated on the randomised phase III multicentre BILCAP clinical trial

dc.contributor.authorCrolley, V. E.en
dc.contributor.authorGuest, R.en
dc.contributor.authorBeggs, A. D.en
dc.contributor.authorJaynes, E.en
dc.contributor.authorThorn, S.en
dc.contributor.authorHerrero, J.en
dc.contributor.authorTomlinson, I.en
dc.contributor.authorValle, Juan Wen
dc.contributor.authorPrimrose, J. N.en
dc.contributor.authorBridgewater, J. A.en
dc.date.accessioned2023-10-25T08:48:33Z
dc.date.available2023-10-25T08:48:33Z
dc.date.issued2023en
dc.identifier.citationCrolley VE, Guest R, Beggs AD, Jaynes E, Thorn S, Herrero J, et al. Investigating alterations in cancer driver genes and other potentially targetable mutations in patients with intrahepatic cholangiocarcinoma (iCCA) treated on the randomised phase III multicentre BILCAP clinical trial. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772000842.en
dc.identifier.doi10.1200/JCO.2023.41.16_suppl.4019en
dc.identifier.urihttp://hdl.handle.net/10541/626640
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2023.41.16_suppl.4019en
dc.titleInvestigating alterations in cancer driver genes and other potentially targetable mutations in patients with intrahepatic cholangiocarcinoma (iCCA) treated on the randomised phase III multicentre BILCAP clinical trialen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUCL-University College London, Londonen
dc.identifier.journalJournal of Clinical Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record